STEPHEN P SQUINTO Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for STEPHEN P SQUINTO.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of STEPHEN P SQUINTO. STEPHEN P SQUINTO is EVP & Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research & Devel in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research & Development in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research and Development in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec. VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP& Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP/Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Chemomab Therapeutics Ltd. ($ANCN) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in SpringWorks Therapeutics, Inc. ($SWTX) and Head of Research and Dev in Passage BIO, Inc. ($PASG).

Latest Insider Trading Transactions of STEPHEN P SQUINTO

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ALXN, BOLD, ANCN, PASG, SWTX

Page: 1 2 3 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 28 2021	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Sell	S	76.20	19,231	1,465,437	125,728	145 K to 125.7 K (-13.27 %)
Apr 28 2021	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Sell	S	75.05	201	15,085	144,959	145.2 K to 145 K (-0.14 %)
Apr 21 2021	ANCN	Chemomab Therapeut ...	SQUINTO STEPHEN P	Director	Option Exercise	A	27.26	23,768	647,916	23,768
Apr 19 2021	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Sell	S	75.01	1,057	79,291	145,160	146.2 K to 145.2 K (-0.72 %)
Apr 19 2021	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Sell	S	75.08	511	38,365	146,217	146.7 K to 146.2 K (-0.35 %)
May 22 2020	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	A	38.03	7,464	283,856	7,464
Mar 13 2020	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	A	28.76	20,000	575,200	20,000
Mar 02 2020	PASG	Passage BIO, Inc.	SQUINTO STEPHEN P	Head of Research an ...	Option Exercise	A	18.00	33,836	609,048	33,836
Mar 02 2020	PASG	Passage BIO, Inc.	SQUINTO STEPHEN P	Head of Research an ...	Option Exercise	A	18.00	185,776	3,343,968	185,776
Sep 19 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	C	0.00	1,053,204	0	0
Sep 19 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	C	0.00	6,078,103	0	0
Sep 19 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Buy	P	18.00	275,000	4,950,000	7,406,307	7.1 M to 7.4 M (+3.86 %)
Sep 19 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Buy	C	0.00	1,053,204	0	7,131,307	6.1 M to 7.1 M (+17.33 %)
Sep 19 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Buy	C	0.00	6,078,103	0	6,078,103	0 to 6.1 M
Sep 16 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	A	0.00	6,931,142	0	1,053,204
Sep 16 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	A	0.00	40,000,000	0	6,078,103
Sep 16 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	A	18.00	29,983	539,694	29,983
Sep 16 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	A	0.00	6,931,142	0	1,053,204
Sep 16 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	A	0.00	40,000,000	0	6,078,103
Sep 16 2019	SWTX	SpringWorks Therap ...	SQUINTO STEPHEN P	Director	Option Exercise	A	18.00	29,983	539,694	29,983
Oct 10 2017	BOLD	Audentes Therapeut ...	SQUINTO STEPHEN P	Director	Option Exercise	A	26.01	9,000	234,090	9,000
Aug 25 2016	BOLD	Audentes Therapeut ...	SQUINTO STEPHEN P	Director	Option Exercise	A	15.03	9,000	135,270	9,000
Oct 28 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	78.88	3,075	242,556	7,737
Oct 28 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	42.66	2,475	105,584	0
Oct 28 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	189.00	2,069	391,041	106,508	108.6 K to 106.5 K (-1.91 %)
Oct 28 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	188.36	3,841	723,491	108,577	112.4 K to 108.6 K (-3.42 %)
Oct 28 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	78.88	3,075	242,556	112,418	109.3 K to 112.4 K (+2.81 %)
Oct 28 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	42.66	2,475	105,584	109,343	106.9 K to 109.3 K (+2.32 %)
Oct 07 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	42.66	10,025	427,667	2,475
Oct 07 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	174.95	4,925	861,629	106,868	111.8 K to 106.9 K (-4.41 %)
Oct 07 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	169.95	5,100	866,745	111,793	116.9 K to 111.8 K (-4.36 %)
Oct 07 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	42.66	10,025	427,667	116,893	106.9 K to 116.9 K (+9.38 %)
Sep 26 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	159.50	76	12,122	106,868	106.9 K to 106.9 K (-0.07 %)
Aug 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	157.42	1,662	261,632	106,944	108.6 K to 106.9 K (-1.53 %)
Mar 04 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	A	176.80	49,200	8,698,560	49,200
Mar 04 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Grant	A	0.00	4,000	0	108,606	104.6 K to 108.6 K (+3.82 %)
Feb 10 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	93.83	3,800	356,554	0
Feb 10 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	167.31	1,635	273,552	101,308	102.9 K to 101.3 K (-1.59 %)
Feb 10 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	157.51	20	3,150	102,943	103 K to 102.9 K (-0.02 %)
Feb 10 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	155.55	1,600	248,880	102,963	104.6 K to 103 K (-1.53 %)
Feb 10 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Grant	A	0.00	9,745	0	104,563	94.8 K to 104.6 K (+10.28 %)
Feb 10 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	155.11	3,800	589,418	94,818	98.6 K to 94.8 K (-3.85 %)
Feb 10 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	93.83	3,800	356,554	98,618	94.8 K to 98.6 K (+4.01 %)
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	93.83	3,800	356,554	0
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	78.88	10,813	852,929	0
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	42.66	6,250	266,625	0
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	22.90	7,876	180,360	0
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	155.00	29,637	4,593,735	94,818	124.5 K to 94.8 K (-23.81 %)
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	93.83	3,800	356,554	124,455	120.7 K to 124.5 K (+3.15 %)
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	78.88	10,813	852,929	120,655	109.8 K to 120.7 K (+9.84 %)
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	42.66	6,250	266,625	109,842	103.6 K to 109.8 K (+6.03 %)
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	22.90	7,876	180,360	103,592	95.7 K to 103.6 K (+8.23 %)
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	157.10	3,300	518,430	95,716	99 K to 95.7 K (-3.33 %)
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	153.63	3,200	491,616	99,016	102.2 K to 99 K (-3.13 %)
Feb 05 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	157.14	852	133,883	102,216	103.1 K to 102.2 K (-0.83 %)
Jan 31 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	133.21	18	2,398	103,068	103.1 K to 103.1 K (-0.02 %)
Jan 31 2014	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	133.31	1,100	146,641	103,086	104.2 K to 103.1 K (-1.06 %)
Nov 05 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	42.66	6,250	266,625	0
Nov 05 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	22.90	7,875	180,338	0
Nov 05 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	124.39	1,239	154,119	104,186	105.4 K to 104.2 K (-1.18 %)
Nov 05 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	123.82	12,886	1,595,545	105,425	118.3 K to 105.4 K (-10.89 %)
Nov 05 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	42.66	6,250	266,625	118,311	112.1 K to 118.3 K (+5.58 %)
Nov 05 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	22.90	7,875	180,338	112,061	104.2 K to 112.1 K (+7.56 %)
Oct 30 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	93.83	7,600	713,108	7,600
Oct 30 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	78.88	32,437	2,558,631	32,437
Oct 30 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	123.89	1,000	123,890	104,186	105.2 K to 104.2 K (-0.95 %)
Oct 30 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	124.76	500	62,380	105,186	105.7 K to 105.2 K (-0.47 %)
Oct 30 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	124.06	39,537	4,904,960	105,686	145.2 K to 105.7 K (-27.23 %)
Oct 30 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	93.83	7,600	713,108	145,223	137.6 K to 145.2 K (+5.52 %)
Oct 30 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	78.88	32,437	2,558,631	137,623	105.2 K to 137.6 K (+30.84 %)
Sep 26 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	112.54	304	34,212	105,186	105.5 K to 105.2 K (-0.29 %)
Sep 17 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	114.37	1,000	114,370	105,490	106.5 K to 105.5 K (-0.94 %)
Aug 07 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	116.87	852	99,573	106,490	107.3 K to 106.5 K (-0.79 %)
Aug 02 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	42.66	6,250	266,625	37,500
Aug 02 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	M	22.90	7,875	180,338	15,751
Aug 02 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	116.12	1,392	161,639	107,342	108.7 K to 107.3 K (-1.28 %)
Aug 02 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	114.95	4,858	558,427	108,734	113.6 K to 108.7 K (-4.28 %)
Aug 02 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	116.04	2,963	343,827	113,592	116.6 K to 113.6 K (-2.54 %)
Aug 02 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	115.05	4,912	565,126	116,555	121.5 K to 116.6 K (-4.04 %)
Aug 02 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	42.66	6,250	266,625	121,467	115.2 K to 121.5 K (+5.42 %)
Aug 02 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	22.90	7,875	180,338	115,217	107.3 K to 115.2 K (+7.34 %)
Aug 01 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	110.86	1,120	124,163	107,342	108.5 K to 107.3 K (-1.03 %)
Jul 16 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	S	22.90	11,124	254,740	0
Jul 16 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Option Exercise	S	17.98	6,876	123,630	0
Jul 16 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Sell	S	119.90	18,000	2,158,200	108,462	126.5 K to 108.5 K (-14.23 %)
Jul 16 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	22.90	11,124	254,740	126,462	115.3 K to 126.5 K (+9.64 %)
Jul 16 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Chief Global O ...	Buy	M	17.98	6,876	123,630	115,338	108.5 K to 115.3 K (+6.34 %)
Jul 03 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Option Exercise	M	22.90	7,875	180,338	11,124
Jul 03 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Option Exercise	M	42.66	36,250	1,546,425	0
Jul 03 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Sell	S	97.46	40	3,898	108,462	108.5 K to 108.5 K (-0.04 %)
Jul 03 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Sell	S	96.84	7,285	705,479	108,502	115.8 K to 108.5 K (-6.29 %)
Jul 03 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Sell	S	95.16	11,625	1,106,235	115,787	127.4 K to 115.8 K (-9.12 %)
Jul 03 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Sell	S	94.34	25,175	2,375,010	127,412	152.6 K to 127.4 K (-16.50 %)
Jul 03 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Buy	M	22.90	7,875	180,338	152,587	144.7 K to 152.6 K (+5.44 %)
Jul 03 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Buy	M	42.66	36,250	1,546,425	144,712	108.5 K to 144.7 K (+33.42 %)
May 01 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Option Exercise	M	42.66	20,000	853,200	30,000
May 01 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Option Exercise	M	22.90	16,499	377,827	18,999
May 01 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Sell	S	99.51	200	19,902	108,462	108.7 K to 108.5 K (-0.18 %)
May 01 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Sell	S	98.96	36,299	3,592,149	108,662	145 K to 108.7 K (-25.04 %)
May 01 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Buy	M	42.66	20,000	853,200	144,961	125 K to 145 K (+16.00 %)
May 01 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Global Ops. Of ...	Buy	M	22.90	16,499	377,827	124,961	108.5 K to 125 K (+15.21 %)
Mar 12 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Option Exercise	M	22.90	6,250	143,125	59,124
Mar 12 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Option Exercise	M	17.98	13,750	247,225	6,876
Mar 12 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Sell	S	92.17	3,085	284,344	108,462	111.5 K to 108.5 K (-2.77 %)
Mar 12 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Sell	S	91.21	16,915	1,542,817	111,547	128.5 K to 111.5 K (-13.17 %)
Mar 12 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Buy	M	22.90	6,250	143,125	128,462	122.2 K to 128.5 K (+5.11 %)
Mar 12 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Buy	M	17.98	13,750	247,225	122,212	108.5 K to 122.2 K (+12.68 %)
Feb 08 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Option Exercise	A	93.83	60,800	5,704,864	60,800
Feb 08 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Grant	A	0.00	4,500	0	108,462	104 K to 108.5 K (+4.33 %)
Feb 06 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Sell	S	96.49	52	5,017	81,925	82 K to 81.9 K (-0.06 %)
Feb 06 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Sell	S	95.66	2,520	241,063	81,977	84.5 K to 82 K (-2.98 %)
Jan 30 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Sell	S	94.32	767	72,343	84,497	85.3 K to 84.5 K (-0.90 %)
Jan 30 2013	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Head of R&D	Sell	S	94.50	715	67,568	85,264	86 K to 85.3 K (-0.83 %)
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	22.90	60,626	1,388,335	0
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	17.98	39,374	707,945	0
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	105.01	1,015	106,585	85,979	87 K to 86 K (-1.17 %)
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	106.14	668	70,902	86,994	87.7 K to 87 K (-0.76 %)
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	108.88	16,300	1,774,744	87,662	104 K to 87.7 K (-15.68 %)
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	107.75	38,951	4,196,970	103,962	142.9 K to 104 K (-27.26 %)
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	106.93	19,069	2,039,048	142,913	162 K to 142.9 K (-11.77 %)
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	105.86	25,680	2,718,485	161,982	187.7 K to 162 K (-13.68 %)
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Buy	M	22.90	60,626	1,388,335	187,662	127 K to 187.7 K (+47.72 %)
Jul 31 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Buy	M	17.98	39,374	707,945	127,036	87.7 K to 127 K (+44.92 %)
Jul 11 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	17.98	50,000	899,000	0
Jul 11 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	101.81	1,200	122,172	87,662	88.9 K to 87.7 K (-1.35 %)
Jul 11 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	100.98	4,700	474,606	88,862	93.6 K to 88.9 K (-5.02 %)
Jul 11 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	100.34	44,100	4,424,994	93,562	137.7 K to 93.6 K (-32.03 %)
Jul 11 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Buy	M	17.98	50,000	899,000	137,662	87.7 K to 137.7 K (+57.04 %)
Jun 08 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	17.65	44,336	782,530	0
Jun 08 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	17.65	5,664	99,970	0
Jun 08 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	90.00	50,000	4,500,000	87,662	137.7 K to 87.7 K (-36.32 %)
Jun 08 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Buy	M	17.65	50,000	882,500	137,662	87.7 K to 137.7 K (+57.04 %)
Feb 22 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	17.65	50,000	882,375	44,336
Feb 22 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	11.92	5,260	62,673	0
Feb 22 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	82.03	6,779	556,081	87,662	94.4 K to 87.7 K (-7.18 %)
Feb 22 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	81.27	48,481	3,939,857	94,441	142.9 K to 94.4 K (-33.92 %)
Feb 22 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Buy	M	17.65	50,000	882,375	142,922	92.9 K to 142.9 K (+53.81 %)
Feb 22 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Buy	M	11.92	5,260	62,673	92,922	87.7 K to 92.9 K (+6.00 %)
Feb 06 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	78.88	86,500	6,823,120	86,500
Feb 06 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Buy	M	0.00	13,000	0	87,662	74.7 K to 87.7 K (+17.41 %)
Jan 30 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	74.51	3,004	223,828	74,662	77.7 K to 74.7 K (-3.87 %)
Jan 30 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	74.41	663	49,334	77,626	78.3 K to 77.6 K (-0.85 %)
Jan 11 2012	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	75.00	562	42,150	78,289	78.9 K to 78.3 K (-0.71 %)
Oct 25 2011	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	11.92	52,740	628,661	0
Oct 25 2011	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	69.61	30,873	2,149,070	78,851	109.7 K to 78.9 K (-28.14 %)
Oct 25 2011	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	68.84	21,867	1,505,324	109,724	131.6 K to 109.7 K (-16.62 %)
Oct 25 2011	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Buy	M	11.92	52,740	628,661	131,591	78.9 K to 131.6 K (+66.89 %)
Oct 25 2011	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Grant	A	0.00	1,250	0	78,851	77.6 K to 78.9 K (+1.61 %)
Jul 27 2011	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Option Exercise	M	10.29	28,000	288,120	0
Jul 27 2011	ALXN	ALEXION PHARMACEUT ...	SQUINTO STEPHEN P	EVP, Research & Dev ...	Sell	S	57.27	669	38,314	77,601	78.3 K to 77.6 K (-0.85 %)

Page: 1 2 3 next >